openPR Logo
Press release

Big Data to render Kingship to Peptic Ulcer Drugs Market between 2020-2030, reaching US$ 47.7 Bn

05-20-2022 07:45 AM CET | Health & Medicine

Press release from: Persistence Market Research

Big Data to render Kingship to Peptic Ulcer Drugs Market between

The Peptic Ulcer Drugs Market is expected to grow on a decent note, i.e. reach US$ 47.7 Bn between 2020-2030. VR-based healthcare solution providers are creating ripples and are expected to continue with the same even in the forecast period. The services include critical procedure simulations, medical training, stroke rehabilitation, non-motor and motor rehabilitation, pain relief, autism care, anxiety reduction, and even battling depression. This would be the case with the healthcare vertical shortly.

Surge in the consumption of NSAIDs due to growing prevalence of inflammatory diseases is the major factor driving the growth of the global peptic ulcer drugs market. Other trends driving growth include increasing adoption of peptic ulcer drugs over surgery, changes in disease management, prevalence of stress ulcers due to higher smoking rates, availability of affordable therapy due to improvements in the service sector, and increasing awareness toward disease management through government campaigns.

Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/3704

However, chronic side-effects associated with the long-term use of peptic ulcer drugs is a factor hampering the growth of the global peptic ulcer drugs market to some extent.

As per PMR analysis, the global peptic ulcer drugs market is set for steady growth over the next ten years, to be valued at US$ 47.7 Bn by 2030-end.

Company Profiles:

Pfizer Inc.
Abbvie Inc.
GlaxoSmithKline plc.
AstraZeneca plc
Boehringer Ingelheim GmbH
Daewoong Pharmaceutical Co., Ltd.
Takeda Pharmaceutical
Eisai Co. Ltd.
Cadila Healthcare Ltd.
Yuhan Corporation

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/3704

Key Takeaways from Peptic Ulcer Drugs Market Study

By product, the proton pump inhibitors segment was the largest revenue generating segment in the historical years. However, revenue from the potassium-competitive acid blockers segment is expected to expand rapidly, owing to the introduction of new P-CAB drugs in the market.
Based on indication, the gastric ulcers segment is anticipated to expand at the highest CAGR of 3% over the forecast period.
On the basis of distribution channel, the hospital pharmacies segment led the global peptic ulcer drugs market, and is expected to remain the leading segment ahead too. Increasing hospitalization rates due to ulcer complications are expected to be the primary factor fuelling revenue growth of the segment over the forecast period.
North America holds the largest share in the global peptic ulcer drugs market, followed by Europe and East Asia.
Due to the worldwide COVID-19 outbreak, physician and hospital visits for non-essential treatment have reduced considerably, putting breaks on the progress of the peptic ulcer drugs market space.

"Increasing NSAID consumption is the major boosting factor for the growth of the global peptic ulcer drugs market," says a PMR analyst.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/3704

Peptic Ulcer Drugs Market: Competition Analysis

Key players operating in the global peptic ulcer drugs market are Daewoong Pharmaceutical Co. Ltd., Takeda Pharmaceutical Company Limited, Pfizer Inc., Abbott Laboratories, AstraZeneca Plc., Cadila Healthcare Ltd., Boehringer Ingelheim GmbH, Eisai Co. Ltd., Yuhan Corporation, and GlaxoSmithKline Pharmaceuticals Ltd. These companies are primarily focusing on strategies such as co-promotions and co-marketing of their brands to penetrate the fastest-growing emerging markets across the world.

What Else is in the Report?

Persistence Market Research offers a unique perspective and actionable insights on the peptic ulcer drugs market in its latest study, presenting historical demand assessment of 2015-2019 and projections for 2020-2030. Research of this report has been done based segmentation into product, indication, and distribution channel, across seven key regions of the world.

Complete Report Details@ https://www.persistencemarketresearch.com/market-research/peptic-ulcer-drugs-market.asp

Contact Us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com

About Us:

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Big Data to render Kingship to Peptic Ulcer Drugs Market between 2020-2030, reaching US$ 47.7 Bn here

News-ID: 2630950 • Views:

More Releases from Persistence Market Research

North America Wiring Devices Market Projected to Reach USD 26.46 Billion by 2031
North America Wiring Devices Market Projected to Reach USD 26.46 Billion by 2031
Overview of the North America Wiring Devices Market The North America wiring devices market is poised for steady growth over the forecast period, with its size estimated at US$ 18.96 billion in 2024, projected to reach US$ 26.46 billion by 2031, reflecting a CAGR of 4.9%. The market is witnessing substantial expansion due to increasing urbanization, a rising number of residential and commercial construction projects, and the adoption of energy-efficient and
Global Forged Automotive Components Market Poised for Steady Growth, Projected to Reach US$ 70.7 Billion by 2032
Global Forged Automotive Components Market Poised for Steady Growth, Projected t …
The global forged automotive components market is on a robust growth trajectory, currently valued at approximately US$ 50.3 billion in 2025 and forecasted to expand to US$ 70.7 billion by the end of 2032. This growth represents a compound annual growth rate (CAGR) of 5.0% over the coming decade, driven by increasing automotive production, technological advancements, and evolving consumer preferences toward durable, high-performance vehicle parts. Forged automotive components are critical to
Global Electric Cargo Bike Market Set to Accelerate at 11.9% CAGR, Reaching US$ 2.14 Billion by 2032, Reports Persistence Market Research
Global Electric Cargo Bike Market Set to Accelerate at 11.9% CAGR, Reaching US$ …
The global electric cargo bike market is set to experience substantial growth over the coming decade, with Persistence Market Research (PMR) forecasting a compound annual growth rate (CAGR) of 11.9% from 2023 through 2032. Valued at approximately US$ 800 million in 2021, the market is expected to surge to a projected valuation of US$ 2.14 billion by the end of 2032. Notably, electric cargo bikes accounted for 66.2% of the
Bicycle Bearings Market Set for Steady Growth with 6.5% CAGR Through 2032, Driven by Urbanization and Demographic Trends
Bicycle Bearings Market Set for Steady Growth with 6.5% CAGR Through 2032, Drive …
The global bicycle bearings market is poised for significant expansion over the forecast period of 2025 to 2032, according to the latest report released by Persistence Market Research. Valued at approximately US$ 5.99 billion in 2024, the market is projected to reach US$ 6.35 billion by 2025 and further escalate to nearly US$ 9.86 billion by 2032. This growth trajectory reflects a compound annual growth rate (CAGR) of 6.5%, underscoring

All 5 Releases


More Releases for Peptic

Peptic Ulcers Pipeline Insight 2025: Emerging Therapies and Clinical Trials Shap …
DelveInsight's "Peptic Ulcers - Pipeline Insight, 2025" examines over 8+ therapies in development for peptic ulcer disease, a condition affecting millions worldwide with peptic ulcer disease symptoms such as abdominal pain, bloating, nausea, and gastrointestinal bleeding. Despite widespread use of existing peptic ulcer disease treatments, including proton pump inhibitors, H2 blockers, and antibiotics for H. pylori eradication, patients with recurrent or complicated peptic ulcers continue to face significant unmet needs,
Peptic Ulcer Market New Product Development & Latest Trends
Introduction Peptic ulcers are open sores that develop on the inner lining of the stomach and the upper portion of the small intestine. They are primarily caused by Helicobacter pylori (H. pylori) infection, long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs), smoking, alcohol consumption, and stress-related factors. Symptoms include abdominal pain, bloating, indigestion, and, in severe cases, gastrointestinal bleeding or perforation. Despite improved therapeutic options, peptic ulcers remain a major healthcare concern worldwide
Evolving Market Trends In The Peptic Ulcer Industry: Advancements In Peptic Ulce …
The Peptic Ulcer Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Peptic Ulcer Market Size During the Forecast Period? In recent times, there has been a consistent expansion in the peptic ulcer market size. It is projected to escalate from $4.1 billion
Key Influencer in the Peptic Ulcer Market 2025: Obesity Fuels The Expansion Of T …
What Is the Forecasted Market Size and Growth Rate for the Peptic Ulcer Market? The peptic ulcer market has grown steadily in recent years. It will rise from $4.1 billion in 2024 to $4.24 billion in 2025, at a CAGR of 3.5%. This growth is attributed to the rising prevalence of Helicobacter pylori infection, increased use of nonsteroidal anti-inflammatory drugs (NSAIDs), changing lifestyles and dietary habits, awareness campaigns, and a focus
Peptic Ulcer Drugs Market - Relief Within Reach: Transforming Treatment for Pept …
Newark, New Castle, USA - new report, titled Peptic Ulcer Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Peptic Ulcer Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Peptic Ulcer Drugs market. The report offers an overview of
Peptic Ulcer Market Shares, Strategies, and Forecasts Analysis
Sores that develop on the lining of stomach, esophagus, and intestines are called peptic ulcers. Symptoms of peptic ulcers include vomiting, burning stomach pain, bloating, and food intolerance. These can be of three types: gastric ulcers, duodenal ulcers, and esophageal ulcers. Some of the causes of peptic ulcers are stomach infections caused by H. pylori, alcoholism, stomach cancers, usage of anti-inflammatory drugs such as aspirin, and smoking. Peptic ulcers, if